Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/15/2023 | 220.7% | Raymond James | $20 → $22 | Maintains | Strong Buy |
06/22/2023 | 191.55% | Guggenheim | → $20 | Initiates Coverage On | → Buy |
06/14/2023 | 104.08% | Chardan Capital | → $14 | Initiates Coverage On | → Buy |
05/24/2023 | 191.55% | Raymond James | → $20 | Initiates Coverage On | → Strong Buy |
What is the target price for Zura Bio (ZURA)?
The latest price target for Zura Bio (NASDAQ: ZURA) was reported by Raymond James on August 15, 2023. The analyst firm set a price target for $22.00 expecting ZURA to rise to within 12 months (a possible 220.70% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Zura Bio (ZURA)?
The latest analyst rating for Zura Bio (NASDAQ: ZURA) was provided by Raymond James, and Zura Bio maintained their strong buy rating.
When is the next analyst rating going to be posted or updated for Zura Bio (ZURA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zura Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zura Bio was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.
Is the Analyst Rating Zura Bio (ZURA) correct?
While ratings are subjective and will change, the latest Zura Bio (ZURA) rating was a maintained with a price target of $20.00 to $22.00. The current price Zura Bio (ZURA) is trading at is $6.86, which is out of the analyst's predicted range.